EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.4.21.55 | diisopropyl fluorophosphate | inhibits esterase activity | Ovophis okinavensis | |
3.4.21.55 | tosyl-L-lysine chloromethyl ketone | less effective on esterase activity than diisopropyl fluorophospate | Ovophis okinavensis |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.21.55 | soluble | - |
Ovophis okinavensis | - |
- |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.4.21.55 | additional information | - |
amino acid composition | Ovophis okinavensis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.55 | Ovophis okinavensis | - |
Himehabu snake | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.4.21.55 | - |
Ovophis okinavensis |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.21.55 | venom | - |
Ovophis okinavensis | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
3.4.21.55 | additional information | - |
42 equivalent to NIH (National Institute of Health)-units of thrombin | Ovophis okinavensis |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.55 | Fibrinogen + H2O | - |
Ovophis okinavensis | Fibrinopeptide A + fibrinopeptide B + ? | - |
? | |
3.4.21.55 | Nalpha-benzoyl-L-Arg 4-nitroanilide + H2O | - |
Ovophis okinavensis | ? | - |
? | |
3.4.21.55 | Tosyl-L-Arg methyl ester + H2O | - |
Ovophis okinavensis | ? | - |
? |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.4.21.55 | additional information | - |
pI: 8.2 | Ovophis okinavensis |
3.4.21.55 | 8 | - |
- |
Ovophis okinavensis |